Skip to main content
Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · VNDA ISIN · US9216591084 LEI · 529900AY8VOOQBKJ0O70 US Manufacturing
Filings indexed 1,021 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US VNDA

About Vanda Pharmaceuticals Inc.

https://www.vandapharma.com/

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies. The company aims to address high unmet medical needs, with a particular focus on treatments for central nervous system disorders. Its portfolio includes both commercialized products and a pipeline of clinical-stage therapies.

Recent filings

Filing Released Lang Actions
10-Q - Vanda Pharmaceuticals Inc. (0001347178) (Filer)
Interim / Quarterly Report
2026-05-07 English
ARS - Vanda Pharmaceuticals Inc. (0001347178) (Filer)
Annual Report
2026-04-23 English
DEF 14A - Vanda Pharmaceuticals Inc. (0001347178) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English
8-K - Vanda Pharmaceuticals Inc. (0001347178) (Filer)
Regulatory Filings
2026-04-22 English
SCHEDULE 13G/A - Vanda Pharmaceuticals Inc. (0001347178) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - VANDA PHARMACEUTICALS INC. (0001347178) (Filer)
Director's Dealing
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.